- Home
- CLRB vs BREA Comparison
CLRB vs BREA Comparison
Compare CLRB & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- BREA
- Stock Information
- Founded
- CLRB 2002
- BREA 2022
- Country
- CLRB United States
- BREA Ireland
- Employees
- CLRB N/A
- BREA N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- BREA Services-Misc. Amusement & Recreation
- Sector
- CLRB Health Care
- BREA Consumer Discretionary
- Exchange
- CLRB Nasdaq
- BREA Nasdaq
- Market Cap
- CLRB 10.7M
- BREA 9.1M
- IPO Year
- CLRB N/A
- BREA 2023
- Fundamental
- Price
- CLRB $0.25
- BREA $0.67
- Analyst Decision
- CLRB Buy
- BREA
- Analyst Count
- CLRB 2
- BREA 0
- Target Price
- CLRB $28.00
- BREA N/A
- AVG Volume (30 Days)
- CLRB 3.8M
- BREA 496.6K
- Earning Date
- CLRB 11-18-2024
- BREA 12-27-2024
- Dividend Yield
- CLRB N/A
- BREA N/A
- EPS Growth
- CLRB N/A
- BREA N/A
- EPS
- CLRB N/A
- BREA N/A
- Revenue
- CLRB N/A
- BREA $1,268,367.00
- Revenue This Year
- CLRB N/A
- BREA N/A
- Revenue Next Year
- CLRB N/A
- BREA N/A
- P/E Ratio
- CLRB N/A
- BREA N/A
- Revenue Growth
- CLRB N/A
- BREA 606.55
- 52 Week Low
- CLRB $0.23
- BREA $0.50
- 52 Week High
- CLRB $4.45
- BREA $3.00
- Technical
- Relative Strength Index (RSI)
- CLRB 6.45
- BREA 47.87
- Support Level
- CLRB $0.23
- BREA $0.67
- Resistance Level
- CLRB $0.28
- BREA $0.73
- Average True Range (ATR)
- CLRB 0.07
- BREA 0.10
- MACD
- CLRB -0.10
- BREA 0.01
- Stochastic Oscillator
- CLRB 2.70
- BREA 23.91
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
About BREA Brera Holdings PLC
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.